Journey Medical Corporation
DERM
$5.01
$0.010.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.13% | 39.01% | 6.80% | -367.78% | 163.64% |
| Total Depreciation and Amortization | 0.18% | 0.00% | 0.00% | 8.28% | 19.83% |
| Total Amortization of Deferred Charges | -4.07% | -0.81% | 22.77% | 7.45% | 8.05% |
| Total Other Non-Cash Items | -10.16% | 115.64% | -41.04% | 41.74% | -9.70% |
| Change in Net Operating Assets | -148.74% | -528.17% | 151.16% | 0.00% | -66.93% |
| Cash from Operations | -163.70% | -152.97% | 66.74% | -227.28% | 292.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 10,200.00% |
| Total Debt Repaid | -- | -- | 100.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -23.72% | 4,210.91% | -96.09% | -32.38% | 1,538.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -22.90% | 4,165.45% | -95.41% | -66.13% | 3,711.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.43% | 699.10% | -201.57% | 135.48% | -48.59% |